Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


Articles published in Stroke

Retrieve available abstracts of 53 articles:
HTML format
Text format



Single Articles


    July 2018
  1. KIM TH, Yang PS, Yu HT, Jang E, et al
    Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation: Cohort Data Covering the Entire Korean Population.
    Stroke. 2018 Jul 16. pii: STROKEAHA.118.021047.
    PubMed     Text format     Abstract available


  2. FROST L, Johnsen SP
    Age and Risk of Stroke in Asians With Atrial Fibrillation: The Clock Is Ticking.
    Stroke. 2018 Jul 16. pii: STROKEAHA.118.022038.
    PubMed     Text format    


  3. LAMSAM L, Sussman ES, Iyer AK, Bhambhvani HP, et al
    Intracranial Hemorrhage in Deep Vein Thrombosis/Pulmonary Embolus Patients Without Atrial Fibrillation: Direct Oral Anticoagulants Versus Warfarin.
    Stroke. 2018 Jul 10. pii: STROKEAHA.118.022156.
    PubMed     Text format     Abstract available


    May 2018
  4. GUROL ME
    Secondary Stroke Prevention in Atrial Fibrillation: New Insights Into an Old Problem.
    Stroke. 2018 May 8. pii: STROKEAHA.118.021262. doi: 10.1161/STROKEAHA.118.021262
    PubMed     Text format    


  5. REDDY VY, Akehurst RL, Amorosi SL, Gavaghan MB, et al
    Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation.
    Stroke. 2018 May 8. pii: STROKEAHA.117.018825. doi: 10.1161/STROKEAHA.117.018825
    PubMed     Text format     Abstract available


    March 2018
  6. YOUSUFUDDIN M, Young N, Keenan L, Olson T, et al
    Five-Year Mortality After Transient Ischemic Attack: Focus on Cardiometabolic Comorbidity and Hospital Readmission.
    Stroke. 2018;49:730-733.
    PubMed     Text format     Abstract available


    January 2018
  7. LINDLEY RI
    Stroke Prevention in the Very Elderly.
    Stroke. 2018 Jan 25. pii: STROKEAHA.117.017952.
    PubMed     Text format    


  8. FISHER M, Hill JA
    Ischemic Stroke Mandates Cross-Disciplinary Collaboration.
    Stroke. 2018 Jan 8. pii: STROKEAHA.117.020014. doi: 10.1161/STROKEAHA.117.020014
    PubMed     Text format    


    December 2017
  9. GUROL ME
    Nonpharmacological Management of Atrial Fibrillation in Patients at High Intracranial Hemorrhage Risk.
    Stroke. 2017 Dec 4. pii: STROKEAHA.117.017081. doi: 10.1161/STROKEAHA.117.017081
    PubMed     Text format    



  10. Correction to: Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.
    Stroke. 2017;48:e368.
    PubMed     Text format    


    November 2017
  11. PROIETTI M, Romanazzi I, Romiti GF, Farcomeni A, et al
    Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Stroke. 2017 Nov 22. pii: STROKEAHA.117.018395.
    PubMed     Text format     Abstract available


  12. YAMADA S, Lin CY, Chang SL, Chao TF, et al
    Risk of Stroke in Patients With Short-Run Atrial Tachyarrhythmia.
    Stroke. 2017 Nov 16. pii: STROKEAHA.117.018475.
    PubMed     Text format     Abstract available


  13. ETHERTON MR, Wu O, Cougo P, Giese AK, et al
    Structural Integrity of Normal Appearing White Matter and Sex-Specific Outcomes After Acute Ischemic Stroke.
    Stroke. 2017 Nov 10. pii: STROKEAHA.117.019258.
    PubMed     Text format     Abstract available


  14. SHOAMANESH A, Charidimou A, Sharma M, Hart RG, et al
    Should Patients With Ischemic Stroke or Transient Ischemic Attack With Atrial Fibrillation and Microbleeds be Anticoagulated?
    Stroke. 2017 Nov 7. pii: STROKEAHA.117.018467. doi: 10.1161/STROKEAHA.117.018467
    PubMed     Text format    


    October 2017
  15. VINEREANU D, Lopes RD, Mulder H, Gersh BJ, et al
    Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin.
    Stroke. 2017 Oct 31. pii: STROKEAHA.117.017574.
    PubMed     Text format     Abstract available


  16. CHATURVEDI S, Molina CA, Selim MH, Diener HC, et al
    Off-Label Use of Direct Oral Anticoagulants in Intracerebral Hemorrhage Patients With Prosthetic Valves.
    Stroke. 2017 Oct 13. pii: STROKEAHA.117.017592.
    PubMed     Text format    


  17. CHA MJ, Choi EK, Han KD, Lee SR, et al
    Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation.
    Stroke. 2017 Oct 3. pii: STROKEAHA.117.018773. doi: 10.1161/STROKEAHA.117.018773
    PubMed     Text format     Abstract available


    September 2017
  18. KIM TH, Yang PS, Kim D, Yu HT, et al
    CHA2DS2-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke: A Korean Nationwide Cohort Study.
    Stroke. 2017 Sep 22. pii: STROKEAHA.117.018551.
    PubMed     Text format     Abstract available


  19. HILKENS NA, Algra A, Greving JP
    Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation.
    Stroke. 2017 Sep 20. pii: STROKEAHA.117.019183.
    PubMed     Text format     Abstract available


  20. SELIM M, Diener HC
    Atrial Fibrillation and Microbleeds.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.017085.
    PubMed     Text format    


  21. GOLDSTEIN LB
    Anticoagulation in Patients With Atrial Fibrillation in the Setting of Prior Hemorrhage: An Ongoing Dilemma.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.017082.
    PubMed     Text format    


  22. THIJS V
    Atrial Fibrillation Detection: Fishing for An Irregular Heartbeat Before and After Stroke.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.017083.
    PubMed     Text format    


  23. YAGHI S, Kamel H
    Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.017084.
    PubMed     Text format    


  24. FISHER M
    Introducing Focused Updates in Cerebrovascular Disease.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.019122.
    PubMed     Text format    


  25. DRABIK L, Wolkow P, Undas A
    Fibrin Clot Permeability as a Predictor of Stroke and Bleeding in Anticoagulated Patients With Atrial Fibrillation.
    Stroke. 2017 Sep 13. pii: STROKEAHA.117.018143.
    PubMed     Text format     Abstract available


  26. BISSON A, Clementy N, Bodin A, Angoulvant D, et al
    Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke.
    Stroke. 2017 Sep 1. pii: STROKEAHA.117.018251. doi: 10.1161/STROKEAHA.117.018251
    PubMed     Text format     Abstract available


    August 2017
  27. YOON CY, Noh J, Jhee JH, Chang TI, et al
    Warfarin Use in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Nationwide Population-Based Study.
    Stroke. 2017 Aug 11. pii: STROKEAHA.117.017114.
    PubMed     Text format     Abstract available


  28. THOREN M, Azevedo E, Dawson J, Egido JA, et al
    Predictors for Cerebral Edema in Acute Ischemic Stroke Treated With Intravenous Thrombolysis.
    Stroke. 2017 Aug 3. pii: STROKEAHA.117.018223. doi: 10.1161/STROKEAHA.117.018223
    PubMed     Text format     Abstract available



  29. Correction to: Ischemic Stroke in Nonvalvular Atrial Fibrillation at Warfarin Initiation: Assessment via a Large Insurance Database.
    Stroke. 2017;48:e239.
    PubMed     Text format    


    July 2017
  30. NTAIOS G, Papavasileiou V, Makaritsis K, Vemmos K, et al
    Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Stroke. 2017 Jul 17. pii: STROKEAHA.117.017549.
    PubMed     Text format     Abstract available


  31. MAZUREK M, Shantsila E, Lane DA, Wolff A, et al
    Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry.
    Stroke. 2017 Jul 5. pii: STROKEAHA.116.016146. doi: 10.1161/STROKEAHA.116.016146
    PubMed     Text format     Abstract available


    June 2017
  32. HERNANDEZ I, Saba S, Zhang Y
    Geographic Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial Fibrillation.
    Stroke. 2017 Jun 27. pii: STROKEAHA.117.017683.
    PubMed     Text format     Abstract available


  33. COLEMAN CI, Peacock WF, Bunz TJ, Alberts MJ, et al
    Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Stroke. 2017 Jun 27. pii: STROKEAHA.117.017474.
    PubMed     Text format     Abstract available


  34. GOUNIS MJ, Chapot R
    Histological Composition and the Origin of the Thrombus: A New Diagnostic Assay for Secondary Stroke Prevention?
    Stroke. 2017 Jun 16. pii: STROKEAHA.117.017630.
    PubMed     Text format    


  35. FLINT AC, Conell C, Ren X, Kamel H, et al
    Statin Adherence Is Associated With Reduced Recurrent Stroke Risk in Patients With or Without Atrial Fibrillation.
    Stroke. 2017 Jun 8. pii: STROKEAHA.117.017343. doi: 10.1161/STROKEAHA.117.017343
    PubMed     Text format     Abstract available


    May 2017
  36. APPELROS P, Farahmand B, Terent A, Asberg S, et al
    To Treat or Not to Treat: Anticoagulants as Secondary Preventives to the Oldest Old With Atrial Fibrillation.
    Stroke. 2017 May 9. pii: STROKEAHA.117.016902. doi: 10.1161/STROKEAHA.117.016902
    PubMed     Text format     Abstract available


  37. LUBITZ SA, Parsons OE, Anderson CD, Benjamin EJ, et al
    Atrial Fibrillation Genetic Risk and Ischemic Stroke Mechanisms.
    Stroke. 2017 May 3. pii: STROKEAHA.116.016198. doi: 10.1161/STROKEAHA.116.016198
    PubMed     Text format     Abstract available


    April 2017
  38. KIM TH, Yang PS, Uhm JS, Kim JY, et al
    CHA2DS2-VASc Score (Congestive Heart Failure, Hypertension, Age >/=75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A K
    Stroke. 2017 Apr 28. pii: STROKEAHA.117.016926.
    PubMed     Text format     Abstract available


  39. MACHADO-ALBA JE, Arias-Jaramillo DR, Gaviria-Mendoza A
    Letter by Machado-Alba et al Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis".
    Stroke. 2017 Apr 28. pii: STROKEAHA.117.017375.
    PubMed     Text format    


  40. BAI Y, Shantsila A, Lip GYH
    Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis".
    Stroke. 2017 Apr 28. pii: STROKEAHA.117.017460.
    PubMed     Text format    


  41. TEPPER PG, Liu X, Hamilton M, Mardekian J, et al
    Ischemic Stroke in Nonvalvular Atrial Fibrillation at Warfarin Initiation: Assessment via a Large Insurance Database.
    Stroke. 2017 Apr 26. pii: STROKEAHA.116.015535.
    PubMed     Text format     Abstract available


  42. LUBITZ SA, Seshadri S, Benjamin EJ
    Response by Lubitz et al to Letter Regarding Article, "Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study".
    Stroke. 2017 Apr 17. pii: STROKEAHA.117.017108.
    PubMed     Text format    


  43. SPOSATO LA, Fridman S, Saposnik G
    Letter by Sposato et al Regarding Article, "Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study".
    Stroke. 2017 Apr 17. pii: STROKEAHA.117.017066.
    PubMed     Text format    


  44. COLL-VINENT B, Martin A, Sanchez J, Tamargo J, et al
    Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation).
    Stroke. 2017 Apr 7. pii: STROKEAHA.116.014855. doi: 10.1161/STROKEAHA.116.014855
    PubMed     Text format     Abstract available


    February 2017
  45. MATTSSON N, Kumarathurai P, Larsen BS, Nielsen OW, et al
    Mild Hypokalemia and Supraventricular Ectopy Increases the Risk of Stroke in Community-Dwelling Subjects.
    Stroke. 2017 Feb 7. pii: STROKEAHA.116.015439. doi: 10.1161/STROKEAHA.116.015439
    PubMed     Text format     Abstract available


    January 2017
  46. HOLT TA, Dalton A, Marshall T, Fay M, et al
    Automated Software System to Promote Anticoagulation and Reduce Stroke Risk: Cluster-Randomized Controlled Trial.
    Stroke. 2017 Jan 24. pii: STROKEAHA.116.015468.
    PubMed     Text format     Abstract available


    October 2016
  47. WOOD AD, Mannu GS, Clark AB, Tiamkao S, et al
    Rheumatic Mitral Valve Disease Is Associated With Worse Outcomes in Stroke: A Thailand National Database Study.
    Stroke. 2016 Oct 4. pii: STROKEAHA.116.014512.
    PubMed     Text format     Abstract available


    July 2016
  48. YONG JH, Thavorn K, Hoch JS, Mamdani M, et al
    Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke.
    Stroke. 2016 Jul 28. pii: STROKEAHA.115.011979.
    PubMed     Text format     Abstract available


    June 2016
  49. WINTERHOLLER M, Hollander C, Kerling F, Weber I, et al
    Stroke in Duchenne Muscular Dystrophy: A Retrospective Longitudinal Study in 54 Patients.
    Stroke. 2016 Jun 28. pii: STROKEAHA.116.013678.
    PubMed     Text format     Abstract available


  50. STANNE TM, Aberg ND, Nilsson S, Jood K, et al
    Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke.
    Stroke. 2016 Jun 14. pii: STROKEAHA.115.012383.
    PubMed     Text format     Abstract available


  51. BERROUSCHOT J, Stoll A, Hogh T, Eschenfelder CC, et al
    Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.
    Stroke. 2016 Jun 14. pii: STROKEAHA.116.013550.
    PubMed     Text format     Abstract available


  52. PANDEY A, Patel MR, Willis B, Gao A, et al
    Association Between Midlife Cardiorespiratory Fitness and Risk of Stroke: The Cooper Center Longitudinal Study.
    Stroke. 2016 Jun 9. pii: STROKEAHA.115.011532.
    PubMed     Text format     Abstract available


    May 2016
  53. GIOIA LC, Kate M, Sivakumar L, Hussain D, et al
    Early Rivaroxaban Use After Cardioembolic Stroke May Not Result in Hemorrhagic Transformation: A Prospective Magnetic Resonance Imaging Study.
    Stroke. 2016 May 24. pii: STROKEAHA.116.013491.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: